Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients
dc.contributor.author | Funnell, S. G.P. | |
dc.contributor.author | Dowling, W. E. | |
dc.contributor.author | Muñoz-Fontela, C. | |
dc.contributor.author | Gsell, P. S. | |
dc.contributor.author | Ingber, D. E. | |
dc.contributor.author | Hamilton, G. A. | |
dc.contributor.author | Delang, L. | |
dc.contributor.author | Rocha-Pereira, J. | |
dc.contributor.author | Kaptein, S. | |
dc.contributor.author | Dallmeier, K. H. | |
dc.contributor.author | Neyts, J. | |
dc.contributor.author | Rosenke, K. | |
dc.contributor.author | de Wit, E. | |
dc.contributor.author | Feldmann, H. | |
dc.contributor.author | Maisonnasse, P. | |
dc.contributor.author | Le Grand, R. | |
dc.contributor.author | Frieman, M. B. | |
dc.contributor.author | Coleman, C. M. | |
dc.date.accessioned | 2020-09-10T18:26:55Z | |
dc.date.available | 2020-09-10T18:26:55Z | |
dc.date.issued | 2020-12-01 | |
dc.identifier.uri | http://hdl.handle.net/10713/13675 | |
dc.description.sponsorship | Horizon 2020 Framework Programme | en_US |
dc.description.uri | https://doi.org/10.1038/s41467-020-17907-w | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Springer Nature | en_US |
dc.relation.ispartof | Nature Communications | en_US |
dc.subject.mesh | Chloroquine | en_US |
dc.subject.mesh | COVID-19 | en_US |
dc.subject.mesh | Hydroxychloroquine | en_US |
dc.title | Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1038/s41467-020-17907-w | |
dc.identifier.eid | 2-s2.0-85089895635 | |
dc.identifier.scopusid | SCOPUS_ID:85089895635 | |
dc.source.volume | 11 | |
dc.source.issue | 1 | |
dc.identifier.eissn | 20411723 | |
dc.identifier.journal | Nature Communications |